Organ and Gut Growth (with misuse) Prolonged or high-dose use may lead to non-specific cell growth in internal organs or the intestines, contributing to the "roid gut" or distended abdomen effect seen in some bodybuilders
In addition to influencing steric accessibility to the C326 binding pocket, such substituents could also potentially affect aldehyde reactivity through electronic effects
Retatrutide is a new injectable medication for weight loss and type 2 diabetes still being researched and developed by Eli Lilly
Difficulty concentrating or memory problems
It represents a clinical and mechanistic leap, proving that a synthetic small molecule can activate a receptor long dominated by peptide drugs
However, both medications can cause gastrointestinal side effects such as nausea, vomiting, or diarrhea, which may be intensified when taken together